Literature DB >> 28167439

Configural and scalar invariance of the center for epidemiologic studies depression scale in Egypt and Canada: Differential symptom emphasis across cultures and genders.

Vivian Huang1, Shadi Beshai2, Stephanie Korol3, R Nicholas Carleton4.   

Abstract

BACKGROUND: Depression is a significant contributor of global disease burden. Previous studies have revealed cross-cultural and gender differences in the presentation of depressive symptoms. Using the Center for Epidemiologic Studies-Depression Scale (CES-D), the present study examined differences in self-reported somatic, negative affective, and anhedonia symptoms of depression among Egyptian and Canadian university students.
METHODS: A total of 338 university students completed study questionnaires from two major universities in Egypt (n=152) and Canada (n=186). Symptom domains were calculated based on the 14-item model of the CES-D.
RESULTS: We found significant culture by gender interactions of total CES-D scores, wherein Egyptian females reported higher scores compared to their Canadian and Egyptian male counterparts. LIMITATIONS: Limitations include using analogue student samples and using only one self-report measure to examine different depressive symptom domains.
CONCLUSIONS: Findings of this study provided support that males and females may differentially report depressive symptoms across cultures. Implications of these results are further discussed.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28167439     DOI: 10.1016/j.psychres.2017.01.079

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  1 in total

1.  Positive associations of optimism-pessimism orientation with pro-environmental behavior and subjective well-being: a longitudinal study on quality of life and everyday behavior.

Authors:  Naoko Kaida; Kosuke Kaida
Journal:  Qual Life Res       Date:  2019-08-17       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.